Expanding the Scope of Precision Care for Patients With HR-Positive Breast Cancers: Things You Should Know

Learn from expert faculty as they discuss application of recent clinical evidence to develop personalized treatment plans for HR-positive/HER2-negative early and advanced breast cancer the use of current and emerging oral targeted therapies and strategies to promote adherence with a downloadable slideset from a satellite symposium an on-demand webcast and expert commentary.

Share

Program Content

Activities

HR-Positive Early-Stage Breast Cancer
Assessing Risk and Individualizing Therapy in HR+/HER2- Early Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2022

Expires: June 05, 2023

HR-Positive Metastatic Breast Cancer
Selection and Sequencing of Targeted Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

HR-Positive Breast Cancer
Practical Management of Adverse Events and Strategies to Promote Adherence with Targeted Therapies in HR-Positive Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2022

Expires: June 05, 2023

No activities added yet

Activities

Updates in HR+ Breast Cancer
Key Updates in the Treatment of Hormone Receptor–Positive Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 18, 2022

Expires: July 17, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Lilly

Novartis Pharmaceuticals Corporation

Sanofi Genzyme